Methadone is a μ-opioid receptor agonist with pharmacological effects similar to morphine, providing analgesia while also inducing respiratory depression, miosis, and sedation. Compared to morphine, methadone is characterized by a longer duration of action, a lower propensity for tolerance development, and reduced physical dependence. Since the early 1960s, it has been recognized for its efficacy in detoxification protocols and as a maintenance therapy for heroin dependence.

To support law enforcement efforts, AccuSift provides high-performance competitive antibody pairs for methadone detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: Colloidal Gold: 200 ppb